2 results
Approved WMOPending
To assess the long-term safety and tolerability of 35 mg and 70 mg RVT-101 in subjects with DLB
Approved WMOCompleted
This preliminary quasi experimental study aims to explore the experiences of patients using a newly developed VR application as an adjuvant in the treatment of AUD after clinical detoxification in DSM-5 diagnosed AUD patients. This study aims to…